Stock Events

Stock Events

Check-Cap 

$1.5300
88
-$0.07-4.38% Wednesday 13:30

Statistics

Day High
1.6359
Day Low
1.53
52W High
2.52
52W Low
0.604
Volume
97,417
Avg. Volume
-
Mkt Cap
8.95M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

1JanExpected
Q4 0
-0.4
-0.07
0.27
0.6
Expected EPS
-0.4
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-50.3MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap144.07B
Intuitive Surgical specializes in robotic-assisted surgery, offering an alternative to Check-Cap's non-invasive approach by providing minimally invasive surgical options.
Medtronic
MDT
Mkt Cap107.36B
Medtronic offers a broad range of medical devices that include gastrointestinal and endoscopic products, competing with Check-Cap in the broader market for diagnostic solutions.
Boston Scientific
BSX
Mkt Cap66.54B
Boston Scientific produces endoscopy equipment and devices, offering competitive technologies for diagnosing and managing gastrointestinal conditions.
Guardant Health
GH
Mkt Cap21.22B
Guardant Health offers liquid biopsy tests for cancer detection, providing a non-invasive alternative to traditional and emerging diagnostic methods, including Check-Cap's.
NovoCure
NVCR
Mkt Cap1.89B
NovoCure develops treatment for cancer using Tumor Treating Fields, a different approach but competes for the same oncology market as Check-Cap's diagnostic solutions.
Stryker
SYK
Mkt Cap126.42B
Stryker specializes in medical technologies, including endoscopic and surgical devices, competing in the broader market for medical devices that can be used in diagnosis and treatment of gastrointestinal diseases.

About

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
Show more...
CEO
Mr. David Lontini
Employees
85
Country
Israel
ISIN
IL0011336851

Listings

XNAS
US
MBAI
STU
DE
7CC.STU
MU
DE
7CC.MU
F
DE
7CC.F

0 Comments

Share your thoughts

FAQ

What is Check-Cap stock price today?▼
The current price of CHEK is $1.53 USD — it has decreased by -4.38% in the past 24 hours. Watch Check-Cap stock price performance more closely on the chart.
What is Check-Cap stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Check-Cap stocks are traded under the ticker CHEK.
Is Check-Cap stock price growing?▼
CHEK stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Check-Cap has showed a +102.92% increase.
What is Check-Cap market cap?▼
Today Check-Cap has the market capitalization of 8.95M
What is Check-Cap revenue for the last year?▼
Check-Cap revenue for the last year amounts to 0 USD.
What is Check-Cap net income for the last year?▼
CHEK net income for the last year is -50.3M USD.
How many employees does Check-Cap have?▼
As of July 21, 2026, the company has 85 employees.
In which sector is Check-Cap located?▼
Check-Cap operates in the Health & Wellness sector.
When did Check-Cap complete a stock split?▼
The last stock split for Check-Cap was on November 25, 2022 with a ratio of 1:20.
Where is Check-Cap headquartered?▼
Check-Cap is headquartered in Isfiya, Israel.